5 Most Promising Penny Stocks According to Analysts
Germany-based Affimed N.V. (NASDAQ:AFMD) is working on cancer immunotherapies. Affimed N.V.
Synlogic Inc. (SYBX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 39,510 | $65,904 | +66% | 0% |
| 2. | Citadel Investment Group Ken Griffin | 29,011 | $49,029 | 0% | |
| 3. | Ikarian Capital Neil Shahrestani | 20,422 | $34,513 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.12 | 9,500 | $10,640.00 | 39,500 | 2022-05-24 | Filing | |
| $2.74 | 7,500 | $20,550.00 | 7,500 | 2019-12-13 | Filing | |
| $7.00 | 714,285 | $4,999,995.00 | 2,253,509 | 2015-10-06 | Filing | |
| $7.00 | 857,142 | $5,999,994.00 | 2,974,811 | 2015-10-06 | Filing | |
| $7.00 | 857,142 | $5,999,994.00 | 2,971,517 | 2015-10-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.81 | 157 | $284.17 | 12,744 | 2025-10-29 | Filing | |
| $1.20 | 144 | $172.80 | 12,901 | 2025-04-02 | Filing | |
| $1.33 | 2,107 | $2,802.31 | 13,045 | 2025-02-03 | Filing | |
| $1.40 | 79 | $110.60 | 15,152 | 2024-10-29 | Filing | |
| $1.73 | 188 | $325.24 | 15,231 | 2024-04-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,312,219 | $5,524,781 | 2.37% | |
| 2. | 2,922,772 | $4,875,184 | 0.27% | |
| 3. | 196,461 | $332,019 | 0% | |
| 4. | 67,665 | $114,362 | 0% | |
| 5. | 19,757 | $32,955 | 0% |
News See All
5 Best Rated Penny Stocks to Buy According to Analysts
Germany-based Affimed is trading at $0.64 as of July 13, while its analyst price target is $6. This stock price target shows an upside potential of a whopping 837% from the current levels.
10 Cheap Pharmaceutical Stocks to Watch
In this article, we discuss the 10 cheap pharmaceutical stocks to watch.
Is Synlogic (SYBX) A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Is Synlogic, Inc. (SYBX) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Here is What Hedge Funds Think About Synlogic, Inc. (SYBX)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June.
Synlogic, Inc. (SYBX) Is Burning These Hedge Funds
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.
13G Filing: Eastern Capital Ltd and Synlogic Inc. (SYBX)
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing...
13D Filing: OrbiMed Advisors and Synlogic Inc. (SYBX)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d‑1(e), 240....
Hedge Fund Resource Center Billionaire Hedge Funds
